Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients-Reference-Cited by-同舟云学术

Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients

Published:2013-08-08 Issue:1 Volume:32 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Vici Patrizia,Sergi Domenico,Pizzuti Laura,Mariani Luciano,Arena Maria Grazia,Barba Maddalena,Maugeri-Saccà Marcello,Vincenzoni Cristina,Vizza Enrico,Corrado Giacomo,Paoletti Giancarlo,Tomao Federica,Tomao Silverio,Giannarelli Diana,Di Lauro Luigi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1756-9966-32-49.pdf

Reference50 articles.

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin. 2013, 63: 11-30. 10.3322/caac.21166.

2. Kim A, Ueda Y, Naka T, Enomoto T: Therapeutic strategies in epithelial ovarian cancer. J Exp Clin Cancer Res. 2012, 31: 14-10.1186/1756-9966-31-14.

3. Bruchim I, Jarchowsky-Dolberg O, Fishman A: Advanced (>second) line chemotherapy in the treatment of patients with recurrent epithelial ovarian cancer. Eur J Obstet Gynecol Reprod Biol. 2013, 166: 94-98. 10.1016/j.ejogrb.2012.10.003.

4. BisFung-Kee-Fung M, Oliver T, Elit L, Oza A, Hirte HW, Bryson P: Optimal chemotherapy treatment in women with recurrent ovarian cancer. Curr Oncol. 2007, 14: 195-208. 10.3747/co.2007.148.

5. Lorusso D, Di Stefano A, Fanfani F, Scambia G: Role of gemcitabine in ovarian cancer treatment. Ann Oncol. 2006, 17 (Suppl 5): v188-v194.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytoreductive surgery is feasible in patients with limited regional platinum-resistant recurrent ovarian cancer;World Journal of Surgical Oncology;2023-11-30

2. Rare Epithelial Ovarian Cancers: Low Grade Serous and Mucinous Carcinomas;Cold Spring Harbor Perspectives in Medicine;2023-06-05

3. Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: a retrospective analysis;BMC Cancer;2022-02-16

4. Options for the Treatment of Mucinous Ovarian Carcinoma;Current Treatment Options in Oncology;2021-11-13

5. Efficacy and Safety of Apatinib Combined with Etoposide in Patients with Recurrent Platinum-resistant Epithelial Ovarian Cancer: A Retrospective Study;Journal of Cancer;2020